As expected, in this case, the SERCA activity of tumor xenografts was significantly inhibited by SBF-1 (Figure 5f), with increased SERCA2 protein level and unchanged mRNA level (Supplementary Figure S9). The gene discussed is ATP2A2; the disease is neoplasm.